← Eichor
Condition: Proliferative Vitreoretinopathy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Proliferative Vitreoretinopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER
Phase 2 · 1 location(s) · Cincinnati Eye Institute, Southwest Ohio · NCT06541574Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
Phase 1/Phase 2 · 1 location(s) · Massachusetts Eye and Ear Infirmary · NCT06033703Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy
Phase 2 · 2 location(s) · Unity Health Toronto · NCT05523869REtinal Detachment Outcomes Study
NA · 1 location(s) · CHU de Quebec-Universite Laval · NCT05863312
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.